49 results on '"Huang, Yande"'
Search Results
2. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir
3. Point-to-point iterative learning control with quantised input signal and actuator faults.
4. An Unexpected Degradation Pathway of a 1,2,4-Triazolo[4,3-a]pyridine Derivative: The Formation of 2 Cationic Pseudodimers of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Drug Candidate in a Stressed Capsule Formulation
5. An unexpected side reaction in the transformation of an alcohol to an amine facilitated by triflic anhydride-pyridine
6. Overcoming NMR line broadening of nitrogen containing compounds: A simple solution.
7. Dehydration and Stabilization of a Reactive Tertiary Hydroxyl Group in Solid Oral Dosage Forms of BMS-779788
8. Point-to-Point Iterative Learning Control with Quantized Input Signal and Actuator Faults
9. Wetting Effects Versus Ion Pairs Diffusivity: Interactions of Anionic Surfactants with Highly Soluble Cationic Drugs and Its Impact on Tablet Dissolution
10. Trace level liquid chromatography tandem mass spectrometry quantification of the mutagenic impurity 2-hydroxypyridine N-oxide as its dansyl derivative
11. Surfactant-Mediated Dissolution of Metformin Hydrochloride Tablets: Wetting Effects Versus Ion Pairs Diffusivity
12. An azirine solid-state photodegradant of the CCR2/CCR5 dual antagonist BMS-813160
13. Role of Self-Association and Supersaturation in Oral Absorption of a Poorly Soluble Weakly Basic Drug
14. Degradation Kinetics and Mechanism of an Oxadiazole Derivative, Design of a Stable Drug Product for BMS-708163, a γ-Secretase Inhibitor Drug Candidate
15. Circumventing glass vial and diluent effects on solution stability of small molecule analytes during analytical method development and validation
16. Structural characterization of low level degradants in aztreonam injection and an innovative approach to aid HPLC method validation
17. An Azirine Solid-State Photodegradant of the Ccr2/Ccr5 Dual Antagonist Bms-813160
18. Transition metal-induced degradation of a pharmaceutical compound in reversed-phase liquid chromatographic analysis
19. Optimal Iterative Learning Control of Quantized Signals Based on Encoding-Decoding Method
20. Microbial transformation of 2-amino-4-methyl-3-nitropyridine
21. Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate
22. Identification, evaluation and elimination of transition-metal mediated sample degradation during LC method development
23. Conformational equilibria of phosphoranes with 5-alkyl-substituted 1,3,2-dioxaphosphorinane rings attached diequatorially to five-coordinated phosphorus. Are boat/twist conformations populated?
24. Study of the conformational equilibria of 2-Z-3-methyl-1,3,2-oxazaphosphorinanes. Steric and stereoelectronic influences on the orientation of the Me2N substituent on three-coordinate phosphorus
25. NMR and x-ray evidence for the chair conformation of six-membered rings attached diequatorially to five-coordinate phosphorus. Implications for reported transition-state analogs of nucleoside cyclic 3',5'-monophosphate hydrolysis
26. Oxidative degradation pathways of beclabuvir hydrochloride mediated by hydrogen peroxide and UV/Vis light
27. An unexpected product from the attempted acetal formation of 2,4,6-trihydroxybenzaldehyde
28. Non-enzymatic transformation of dl-glyceraldehyde, 1,3-dihydroxyacetone, and pyruvaldehyde with primary amine to the same dl-alanine derivatives
29. Preparation of the HIV Attachment Inhibitor BMS-663068. Part 9. Active Pharmaceutical Ingredient Process Development and Powder Properties
30. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets
31. Improving the efficiency of quantitative 1H NMR: An innovative external standard–internal reference approach
32. Identification of amino acid derivatives as condensation products between glyceraldehyde and guanine nucleoside
33. Understanding and Controlling the Formation of an Impurity during the Development of Muraglitazar, a PPAR Dual Agonist
34. Identification of Critical Process Impurities and Their Impact on Process Research and Development
35. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.
36. STRUCTURAL ELUCIDATION OF HUMAN OXIDATIVE METABOLITES OF MURAGLITAZAR: USE OF MICROBIAL BIOREACTORS IN THE BIOSYNTHESIS OF METABOLITE STANDARDS
37. Degradation of a Lyophilized Formulation of BMS-204352: Identification of Degradants and Role of Elastomeric Closures
38. Influence of Formaldehyde Impurity in Polysorbate 80 and PEG‐300 on the Stability of a Parenteral Formulation of BMS‐204352: Identification and Control of the Degradation Product
39. Structure-reactivity studies of the triplet-sensitized photorearrangements of allyl phosphites
40. X-RAY CRYSTALLOGRAPHIC STUDY OF PHOSPHORANES. EFFECTS ON EQUATORIAL O–P–O BOND ANGLES OF INCLUSION OF PHOSPHORUS IN A 1,3,2-DIOXAPHOSPHORINANE RING
41. Improving the efficiency of quantitative 1H NMR: An innovative external standard–internal reference approach.
42. X-ray and proton NMR studies of the conformational equilibria of 2-Z-3-phenyl-1,3,2-oxazaphosphorinanes. Steric and stereoelectronic influences on the unexpected axial preferences of Me2N and MeNH substituents on three-coordinate phosphorus
43. X-Ray crystallographic study of a 1,3,2-dioxaphosphorinane dimer containing five-coordinated phosphorus in the 12-membered ring
44. Understanding and Controlling the Formation of an Impurity during the Development of Muraglitazar, a PPAR Dual Agonist.
45. Chair-form six-membered ring attached diequatorially to five-coordinate phosphorus. 1H NMR and x-ray crystallographic study
46. Unexpected axial preference of the Me2N substituent on the phosphorus atom of the P(III) 1,3,2,-oxazaphosphorinane ring system
47. X-ray and 1H NMR studies of the conformational equilibria of...
48. STRUCTURAL ELUCIDATION OF HUMAN OXIDATIVE METABOLITES OF MURAGLITAZAR: USE OF MICROBIAL BIOREACTORS IN THE BIOSYNTHESIS OF METABOLITE STANDARDS
49. Unexpected axial preference of the Me 2N substituent on the phosphorus atom of the P(III) 1,3,2,-oxazaphosphorinane ring system
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.